EXAS vs. DXCM
Compare and contrast key facts about Exact Sciences Corporation (EXAS) and DexCom, Inc. (DXCM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EXAS or DXCM.
Correlation
The correlation between EXAS and DXCM is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
EXAS vs. DXCM - Performance Comparison
Loading data...
Key characteristics
EXAS:
0.15
DXCM:
-0.60
EXAS:
0.56
DXCM:
-0.38
EXAS:
1.08
DXCM:
0.93
EXAS:
0.06
DXCM:
-0.51
EXAS:
0.20
DXCM:
-0.82
EXAS:
22.45%
DXCM:
39.25%
EXAS:
58.98%
DXCM:
58.58%
EXAS:
-98.01%
DXCM:
-94.61%
EXAS:
-63.60%
DXCM:
-47.50%
Fundamentals
EXAS:
$10.64B
DXCM:
$33.52B
EXAS:
-$5.55
DXCM:
$1.33
EXAS:
-1.07
DXCM:
1.32
EXAS:
3.76
DXCM:
8.08
EXAS:
4.42
DXCM:
14.82
EXAS:
$2.83B
DXCM:
$4.15B
EXAS:
$1.93B
DXCM:
$2.46B
EXAS:
-$848.74M
DXCM:
$889.80M
Returns By Period
In the year-to-date period, EXAS achieves a 0.41% return, which is significantly lower than DXCM's 9.91% return. Over the past 10 years, EXAS has underperformed DXCM with an annualized return of 7.84%, while DXCM has yielded a comparatively higher 17.38% annualized return.
EXAS
0.41%
35.69%
14.37%
11.99%
-7.63%
7.84%
DXCM
9.91%
24.66%
12.65%
-34.93%
-3.79%
17.38%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EXAS vs. DXCM — Risk-Adjusted Performance Rank
EXAS
DXCM
EXAS vs. DXCM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Exact Sciences Corporation (EXAS) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
EXAS vs. DXCM - Dividend Comparison
Neither EXAS nor DXCM has paid dividends to shareholders.
Drawdowns
EXAS vs. DXCM - Drawdown Comparison
The maximum EXAS drawdown since its inception was -98.01%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for EXAS and DXCM. For additional features, visit the drawdowns tool.
Loading data...
Volatility
EXAS vs. DXCM - Volatility Comparison
The current volatility for Exact Sciences Corporation (EXAS) is 11.88%, while DexCom, Inc. (DXCM) has a volatility of 17.14%. This indicates that EXAS experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
EXAS vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between Exact Sciences Corporation and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EXAS vs. DXCM - Profitability Comparison
EXAS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a gross profit of 500.55M and revenue of 706.79M. Therefore, the gross margin over that period was 70.8%.
DXCM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a gross profit of 589.00M and revenue of 1.04B. Therefore, the gross margin over that period was 56.9%.
EXAS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported an operating income of -96.01M and revenue of 706.79M, resulting in an operating margin of -13.6%.
DXCM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported an operating income of 133.70M and revenue of 1.04B, resulting in an operating margin of 12.9%.
EXAS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Exact Sciences Corporation reported a net income of -101.22M and revenue of 706.79M, resulting in a net margin of -14.3%.
DXCM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, DexCom, Inc. reported a net income of 105.40M and revenue of 1.04B, resulting in a net margin of 10.2%.